MedPath
FDA Approval

AMINOCAPROIC ACID

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
April 20, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Aminocaproic acid(1000 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Carnegie Pharmaceuticals, LLC

079839141

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Carnegie Pharmaceuticals, LLC

Carnegie Pharmaceuticals, LLC

Carnegie Pharmaceuticals, LLC

079839141

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

AMINOCAPROIC ACID

Product Details

NDC Product Code
80005-129
Application Number
ANDA213928
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
April 20, 2023
Code: U6F3787206Class: ACTIBQuantity: 1000 mg in 1 1
CROSPOVIDONEInactive
Code: 2S7830E561Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
POVIDONEInactive
Code: FZ989GH94EClass: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65APClass: IACT

AMINOCAPROIC ACID

Product Details

NDC Product Code
80005-128
Application Number
ANDA213928
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
April 20, 2023
Code: U6F3787206Class: ACTIBQuantity: 500 mg in 1 1
CROSPOVIDONEInactive
Code: 2S7830E561Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
POVIDONEInactive
Code: FZ989GH94EClass: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65APClass: IACT
© Copyright 2025. All Rights Reserved by MedPath
AMINOCAPROIC ACID - FDA Approval | MedPath